Clinical Characteristics and Epidemiology of Cardiovascular Autonomic Neuropathy in Peoples With Long-Standing Diabetes
- PMID: 40696523
- PMCID: PMC12284305
- DOI: 10.3346/jkms.2025.40.e154
Clinical Characteristics and Epidemiology of Cardiovascular Autonomic Neuropathy in Peoples With Long-Standing Diabetes
Abstract
Background: Cardiovascular autonomic neuropathy (CAN) is a frequently underdiagnosed complication of diabetes mellitus that contributes to increased mortality and morbidity rates. This multicenter study investigated the epidemiology and clinical characteristics of CAN in patients with long-term diabetes.
Methods: Retrospective data were collected from 884 individuals with diabetes who were assessed for CAN across eight hospitals in Korea. CAN was diagnosed using electrocardiography and cardiovascular autonomic function tests, including the heart rate-corrected QT interval and Ewing's method. This study evaluated the clinical characteristics, cardiovascular autonomic nerve function test results, and risk factors associated with CAN.
Results: Among the 884 patients, 778 (88%) were diagnosed with CAN (DCAN), while 106 (12%) were not (non-DCAN). Individuals with DCAN were older, had a longer duration of diabetes, and had higher creatinine levels. The DCAN group showed decreased time and frequency parameters of heart rate variability (HRV). A multiple logistic regression analysis revealed that a longer diabetes duration, older age, and higher creatinine level were significant risk factors for CAN.
Conclusion: CAN was associated with advanced age, a longer duration of diabetes, higher creatinine levels, and lower time and frequency HRV parameters.
Keywords: Cardiovascular Autonomic Neuropathy; Ewing's Method; Heart Rate Variability; Long-Duration Diabetes; QTc Prolongation.
© 2025 The Korean Academy of Medical Sciences.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Similar articles
-
The association of diabetic peripheral neuropathy with cardiac autonomic neuropathy in individuals with diabetes mellitus: A systematic review.J Diabetes Complications. 2024 Aug;38(8):108802. doi: 10.1016/j.jdiacomp.2024.108802. Epub 2024 Jun 28. J Diabetes Complications. 2024. PMID: 38971002
-
Sex Differences in the Association Between Cardiovascular Autonomic Neuropathy and Mortality in Patients With Type 2 Diabetes: The ACCORD Study.J Am Heart Assoc. 2025 Jan 21;14(2):e034626. doi: 10.1161/JAHA.124.034626. Epub 2025 Jan 10. J Am Heart Assoc. 2025. PMID: 39791396 Free PMC article.
-
Reactive Hyperemia and Cardiovascular Autonomic Neuropathy in Type 2 Diabetic Patients: A Systematic Review of Randomized and Nonrandomized Clinical Trials.Medicina (Kaunas). 2023 Apr 16;59(4):770. doi: 10.3390/medicina59040770. Medicina (Kaunas). 2023. PMID: 37109728 Free PMC article.
-
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy.J Diabetes Complications. 2025 Sep;39(9):109107. doi: 10.1016/j.jdiacomp.2025.109107. Epub 2025 Jun 7. J Diabetes Complications. 2025. PMID: 40505203
-
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes.J Am Heart Assoc. 2025 Jan 7;14(1):e036787. doi: 10.1161/JAHA.124.036787. Epub 2024 Dec 27. J Am Heart Assoc. 2025. PMID: 39727210 Free PMC article. Clinical Trial.
References
-
- World Health Organization. FACT SHEET. [Updated 2024]. [Accessed November 14, 2024]. https://www.who.int/news-room/fact-sheets/detail/diabetes .
-
- Kuehl M, Stevens MJ. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012;8(7):405–416. - PubMed
-
- Lee KA, Park TS, Jin HY. Non-glucose risk factors in the pathogenesis of diabetic peripheral neuropathy. Endocrine. 2020;70(3):465–478. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical